Bodor, et al, J. Pharm. Sci., 67, No. 5, 685 (1978). |
Bodor, "Novel Approaches for the Design of Membrane Transport Properties of Drugs," in Design of Biopharmaceutical Properties through Prodrugs and Analogs, Roche, E.B. (ed.), APhA Academy of Pharmaceutical Sciences, Washington, D.C. 98-135 (1976). |
Bodor et al, Science, vol. 214, Dec. 18, 1981, pp. 1370-1372. |
Simpkins and Bodor, "Brain-Enhanced Drug Delivery Systems for the Treatment of Dementia," in Alzheimer's Disease: New Treatment Strategies, eds. Z.S. Khachaturian and J.P. Blass, Marcel Dekker, Inc., New York, 1992. |
Guengerich et al, J. Med. Chem., vol. 34, pp. 1838-1844 (1991). |
Bodor et al, Journal of Molecular Structure (Theochem), 206, pp. 315-334 (1990). |
Bodor et al, Journal of Molecular Structure (Theochem), 163, pp. 315-330 (1988). |
Bodor et al, Tetrahedron, vol. 44, No. 24, pp. 7601-7610 (1988). |
Brewster et al, Fourth Colloquium in Biological Sciences: Blood-Brain Transfer, vol. 529 of the Annals of the New York Academy of Sciences, pp. 298-300, Jun. 14, 1988. |
Simpkins et al, Chapter 4 in Alzheimer's Disease: New Treatment Strategies, eds. Khachaturian and Blass, Marcel Dekker, Inc., New York, pp. 37-55 (1992). |
Bodor et al, Science, vol. 257, pp. 1698-1700, Sep. 18, 1992. |
Thomas, "Medical Progress: Top Ten Advances of 1992," in Harvard Health Letter, vol. 18, No. 5, pp. 1-4, Mar. 1993. |
Pop et al, International Journal of Pharmaceutics, 84, pp. 39-48 (1992). |
Bundgaard, Chapter 1 in Design of Prodrugs, ed. H. Bundgaard, pp. 1-10, 79-83 (1985). |